Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2010 - 2026)

Jazz Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $149.7 million for Q1 2026.

• In Q1 2026, Prepaid Assets fell 42.38% year-over-year to $149.7 million; the TTM figure through Mar 2026 stood at $149.7 million (down 42.38% YoY), while the FY2025 annual figure was $152.5 million, down 14.04% from the prior year.
• Prepaid Assets for Q1 2026 stood at $149.7 million, down from $152.5 million in the prior quarter.
• The five-year high for Prepaid Assets was $320.8 million in Q4 2023, with the low at $72.8 million in Q1 2023.
• The 5-year median for Prepaid Assets is $152.5 million (2025), against an average of $183.4 million.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 164.64% in 2022, then sank 56.01% in 2023.
• Jazz Pharmaceuticals' Prepaid Assets stood at $267.2 million in 2022, then grew by 20.07% to $320.8 million in 2023, then tumbled by 44.7% to $177.4 million in 2024, then slipped by 14.04% to $152.5 million in 2025, then retreated by 1.84% to $149.7 million in 2026.
• Business Quant data shows JAZZ's Prepaid Assets at $149.7 million in Q1 2026, $152.5 million in Q4 2025, and $315.4 million in Q3 2025.